Zobrazeno 1 - 10
of 369
pro vyhledávání: '"Prefasi D"'
Autor:
Meca-Lallana JE, Prefasi D, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, de Castro-Trapiello H, Canal N, Maurino J
Publikováno v:
Patient Preference and Adherence, Vol Volume 15, Pp 713-719 (2021)
Jose E Meca-Lallana,1 Daniel Prefasi,2 Francisco Pérez-Miralles,3 Lucía Forero,4 María Sepúlveda,5 Carmen Calles,6 María L Martínez-Ginés,7 Inés González-Suárez,8 Sabas Boyero,9 Lucía Romero-Pinel,10 Ángel P Sempere,11 Virginia Meca-Lalla
Externí odkaz:
https://doaj.org/article/ea254272f2364493bb87e162db264ba9
Autor:
García-Domínguez JM, Martínez-Ginés ML, Carmona O, Caminero AB, Prefasi D, Maurino J, Ballesteros J
Publikováno v:
Patient Preference and Adherence, Vol Volume 13, Pp 101-106 (2019)
Jose M García-Domínguez,1 María L Martínez-Ginés,1 Olga Carmona,2 Ana B Caminero,3 Daniel Prefasi,4 Jorge Maurino,4 Javier Ballesteros5 On behalf of the W-IMPACT Clinical Investigators 1Department of Neurology, Hospital Universitario Gregorio Ma
Externí odkaz:
https://doaj.org/article/b7f4beec78c748c1874fff3ce16b2646
Autor:
Villarejo-Galende, A. (Alberto), García-Arcelay, E. (Elena), Pinol-Ripoll, G. (Gerard), del Olmo-Rodríguez, A. (Antonio), Viñuela, F. (Félix), Boada, M. (Merce), Franco-Macias, E. (Emilio), Ibáñez de la Pena, A. (Almudena), Riverol-Fernández, M. (Mario), Abizanda-Soler, P. (Pedro), Arroyo, R. (Rafael), Baquero-Toledo, M. (Miquel), Feria-Vilar, I. (Inmaculada), Balasa, M. (Mircea), Berbel, Á. (Ángel), Rodríguez-Rodríguez, E. (Eloy), Vieira-Camposs, A. (Alba), García-Ribas, G. (Guillermo), Rodrigo-Herrero, S. (Silvia), Terrancle, Á. (Ángeles), Prefasi, D. (Daniel), Lleo, A. (Alberto), Maurino, J. (Jorge)
Background: There is a need to better understand the experience of patients living with Alzheimer's disease (AD) in the early stages. Objective: The aim of the study was to evaluate the perception of quality of life in patients with early-stage AD. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::cb3d0c95dc71c56cb8f9744c5402a963
https://hdl.handle.net/10171/66024
https://hdl.handle.net/10171/66024
Autor:
Perez-Miralles F, Prefasi D, Garcia-Merino A, Ara J, Izquierdo G, Meca-Lallana V, Gascon-Gimenez F, Martinez-Gines M, Ramio-Torrenta L, Costa-Frossard L, Fernandez O, Moreno-Garcia S, Maurino J, Carreres-Polo J, Casanova B
Publikováno v:
Brain and Behavior
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Background and purpose Evidence on regional changes resulting from neurodegenerative processes underlying primary progressive multiple sclerosis (PPMS) is still limited. We assessed brain region volumes and their relationship with disability progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3a992f97b3894fb6aba1839a9fef5598
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15417
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15417
Autor:
Perez-Miralles F, Prefasi D, Garcia-Merino A, Ara J, Izquierdo G, Meca-Lallana V, Gascon-Gimenez F, Martinez-Gines M, Ramio-Torrenta L, Costa-Frossard L, Fernandez O, Moreno-Garcia S, Medrano N, Maurino J, Casanova B
Publikováno v:
Multiple Sclerosis and Related Disorders
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Multiple Sclerosis And Related Disorders
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Multiple Sclerosis And Related Disorders
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
BACKGROUND: Primary progressive multiple sclerosis (PPMS) has long been defined by progressive disability accrual in the absence of initial relapses. However, its underlying neurodegenerative process seems to be accompanied by central nervous system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::255f03bbaddf40a68832b9a25c7d0553
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13763
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13763
Autor:
Meca-Lallana JE; Clinical Neuroimmunology Unit and Multiple Sclerosis CSUR, Department of Neurology, Hospital Universitario 'Virgen de la Arrixaca', IMIB-Arrixaca, Murcia, Spain., Gómez-Ballesteros R; Medical Department, Roche Farma, Madrid, Spain. rocio.gomez@roche.com., Pérez-Miralles F; Unit of Neuroimmunology, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Forero L; Department of Neurology, Hospital Universitario Puerta del Mar, Cádiz, Spain., Sepúlveda M; Department of Neurology, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain., Calles C; Department of Neurology, Hospital Universitari Son Espases, Palma de Mallorca, Spain., Martínez-Ginés ML; Department of Neurology, Hospital Universitario Gregorio Marañón, Madrid, Spain., González-Suárez I; Department of Neurology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Boyero S; Department of Neurology, Hospital Universitario Cruces, Bilbao, Spain., Romero-Pinel L; Department of Neurology, Hospital Universitari de Bellvitge, Barcelona, Spain., Sempere ÁP; Department of Neurology, Hospital General Universitario de Alicante, Alicante, Spain., Meca-Lallana V; Department of Neurology, Hospital Universitario La Princesa, Madrid, Spain., Querol L; Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Costa-Frossard L; Department of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Prefasi D; Medical Department, Roche Farma, Madrid, Spain., Maurino J; Medical Department, Roche Farma, Madrid, Spain.
Publikováno v:
Neurology and therapy [Neurol Ther] 2022 Sep; Vol. 11 (3), pp. 1101-1116. Date of Electronic Publication: 2022 May 06.
Autor:
Villarejo-Galende A; Department of Neurology, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., García-Arcelay E; Medical Department, Roche Farma, Madrid, Spain., Piñol-Ripoll G; Cognitive Disorders Unit, Hospital Universitari Santa Maria de Lleida, Institut de Recerca Biomédica de Lleida (IRBLLeida), Lleida, Spain., Del Olmo-Rodríguez A; Department of Neurology, Hospital Universitario Dr. Peset, Valencia, Spain., Viñuela F; Instituto Neurológico Andaluz, Hospital Victoria Eugenia, Unidad Deterioro Cognitivo, Hospital Universitario Virgen Macarena, Sevilla, Spain., Boada M; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain., Franco-Macías E; Dementia Unit, Department of Neurology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain., Ibañez de la Peña A; Centro de Investigación de Parkinson, Policlínica Guipúzcoa, San Sebastián, Spain., Riverol M; Department of Neurology, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain., Puig-Pijoan A; Cognitive Impairment and Movement Disorders Unit, Department of Neurology, Hospital del Mar, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, Spain., Abizanda-Soler P; Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain., Arroyo R; Department of Neurology, Hospital Universitario Quirónsalud, Madrid, Spain., Baquero-Toledo M; Grup d'Investigació en Malaltia d'Alzheimer, Department of Neurology, Hospital Universitari i Politècnic La Fe, Institut d'Investigació Sanitaria La Fe, Valencia, Spain., Feria-Vilar I; Department of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain., Balasa M; Alzheimer's Disease and other Cognitive Disorders Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Berbel Á; Department of Neurology, Hospital Central de la Cruz Roja, Madrid, Spain., Rodríguez-Rodríguez E; Department of Neurology, Hospital Universitario de Marqués de Valdecilla, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain., Vieira-Campos A; Department of Neurology, Hospital Universitario de La Princesa, Madrid, Spain., García-Ribas G; Department of Neurology, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain., Rodrigo-Herrero S; Department of Neurology, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain., Terrancle Á; Medical Department, Roche Farma, Madrid, Spain., Prefasi D; Medical Department, Roche Farma, Madrid, Spain., Lleó A; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Department of Neurology, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain., Maurino J; Medical Department, Roche Farma, Madrid, Spain.
Publikováno v:
Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2022; Vol. 90 (2), pp. 719-726.
Autor:
Meca-Lallana JE; Department of Neurology, Clinical Neuroimmunology Unit and Multiple Sclerosis CSUR, Hospital Universitario 'Virgen de la Arrixaca', IMIB-Arrixaca, Murcia, Spain., Maurino J; Medical Department, Roche Farma, Madrid, Spain., Pérez-Miralles F; Department of Neurology, Unit of Neuroimmunology, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Forero L; Department of Neurology, Hospital Universitario Puerta del Mar, Cádiz, Spain., Sepúlveda M; Department of Neurology, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain., Calles C; Department of Neurology, Hospital Universitari Son Espases, Palma de Mallorca, Spain., Martínez-Ginés ML; Department of Neurology, Hospital Universitario Gregorio Marañón, Madrid, Spain., González-Suárez I; Department of Neurology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Boyero S; Department of Neurology, Hospital Universitario Cruces, Bilbao, Spain., Romero-Pinel L; Department of Neurology, Hospital Universitari de Bellvitge, Barcelona, Spain., Sempere ÁP; Department of Neurology, Hospital General Universitario de Alicante, Alicante, Spain., Meca-Lallana V; Department of Neurology, Hospital Universitario La Princesa, Madrid, Spain., Querol L; Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Costa-Frossard L; Department of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Prefasi D; Medical Department, Roche Farma, Madrid, Spain., Gómez-Ballesteros R; Medical Department, Roche Farma, Madrid, Spain., Ballesteros J; Department of Neurosciences and CIBERSAM, University of Basque Country (UPV/EHU), Leioa, Spain.; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Publikováno v:
PloS one [PLoS One] 2021 Jul 29; Vol. 16 (7), pp. e0255317. Date of Electronic Publication: 2021 Jul 29 (Print Publication: 2021).
Autor:
Pérez-Miralles FC; Neuroimmunology Unit, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Prefasi D; Department of Medical, Roche Farma S.A, Madrid, Spain., García-Merino A; Department of Neurology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain., Ara JR; Department of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Izquierdo G; Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain., Meca-Lallana V; Department of Neurology, Hospital Universitario La Princesa, Madrid, Spain., Gascón-Giménez F; Department of Neurology, Hospital Clínico Universitario de Valencia, Valencia, Spain., Martínez-Ginés ML; Department of Neurology, Hospital Universitario Gregorio Marañón, Madrid, Spain., Ramió-Torrentà L; Girona Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Universitari Josep Trueta and Hospital Santa Caterina, IDIBGI, Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain., Costa-Frossard L; Department of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Fernández Ó; Department of Neurology, Hospital Regional Universitario Carlos Haya, Málaga, Spain., Moreno-García S; Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain., Maurino J; Department of Medical, Roche Farma S.A, Madrid, Spain., Carreres-Polo J; Department of Radiology, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Casanova B; Neuroimmunology Unit, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Publikováno v:
Brain and behavior [Brain Behav] 2021 Apr; Vol. 11 (4), pp. e02044. Date of Electronic Publication: 2021 Jan 23.
Publikováno v:
In Neurología (English Edition) March 2012 27(2):122-124